Liesche-Starnecker, F.; Mayer, K.; Kofler, F.; Baur, S.; Schmidt-Graf, F.; Kempter, J.; Prokop, G.; Pfarr, N.; Wei, W.; Gempt, J.;
et al. Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma. Cancers 2020, 12, 2964.
https://doi.org/10.3390/cancers12102964
AMA Style
Liesche-Starnecker F, Mayer K, Kofler F, Baur S, Schmidt-Graf F, Kempter J, Prokop G, Pfarr N, Wei W, Gempt J,
et al. Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma. Cancers. 2020; 12(10):2964.
https://doi.org/10.3390/cancers12102964
Chicago/Turabian Style
Liesche-Starnecker, Friederike, Karoline Mayer, Florian Kofler, Sandra Baur, Friederike Schmidt-Graf, Johanna Kempter, Georg Prokop, Nicole Pfarr, Wu Wei, Jens Gempt,
and et al. 2020. "Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma" Cancers 12, no. 10: 2964.
https://doi.org/10.3390/cancers12102964
APA Style
Liesche-Starnecker, F., Mayer, K., Kofler, F., Baur, S., Schmidt-Graf, F., Kempter, J., Prokop, G., Pfarr, N., Wei, W., Gempt, J., Combs, S. E., Zimmer, C., Meyer, B., Wiestler, B., & Schlegel, J.
(2020). Immunohistochemically Characterized Intratumoral Heterogeneity Is a Prognostic Marker in Human Glioblastoma. Cancers, 12(10), 2964.
https://doi.org/10.3390/cancers12102964